Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,453 | 59 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $270.64 | 14 | $0 (2023) |
| Alkermes, Inc. | $265.45 | 12 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $226.41 | 4 | $0 (2023) |
| ABBVIE INC. | $178.10 | 6 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $124.38 | 4 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $104.34 | 5 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $96.42 | 5 | $0 (2023) |
| Indivior Inc. | $70.43 | 3 | $0 (2023) |
| Braeburn Inc. | $61.00 | 3 | $0 (2024) |
| ITI, Inc. | $32.01 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $125.02 | 6 | Braeburn Inc. ($61.00) |
| 2023 | $266.59 | 12 | Indivior Inc. ($70.43) |
| 2022 | $403.63 | 18 | Otsuka America Pharmaceutical, Inc. ($141.85) |
| 2021 | $657.38 | 23 | Alkermes, Inc. ($207.98) |
All Payment Transactions
59 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: NEUROSCIENCE | ||||||
| 08/27/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: Opioid Use Disorder | ||||||
| 04/23/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $23.44 | General |
| Category: Psychology/Psychiatric | ||||||
| 03/26/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: Opioid Use Disorder | ||||||
| 02/21/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $21.93 | General |
| Category: Opioid Use Disorder | ||||||
| 02/07/2024 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $21.25 | General |
| Category: CNS | ||||||
| 12/05/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: Neuroscience | ||||||
| 11/15/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: PSYCHIATRY | ||||||
| 10/25/2023 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $23.51 | General |
| Category: Neurology | ||||||
| 10/19/2023 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $26.66 | General |
| Category: Neurology | ||||||
| 09/26/2023 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $27.53 | General |
| Category: OUD | ||||||
| 08/29/2023 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $24.40 | General |
| Category: BH | ||||||
| 08/28/2023 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: PSYCHIATRY | ||||||
| 06/28/2023 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: BH | ||||||
| 02/23/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: Neuroscience | ||||||
| 02/14/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: PSYCHIATRY | ||||||
| 01/26/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $29.54 | General |
| Category: Neuropsychiatry | ||||||
| 01/18/2023 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $24.65 | General |
| Category: PSYCHIATRY | ||||||
| 11/15/2022 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $26.55 | General |
| Category: PSYCHIATRY | ||||||
| 11/03/2022 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: PSYCHIATRY | ||||||
| 08/11/2022 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: Neuroscience | ||||||
| 07/11/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $19.97 | General |
| Category: Central Nervous System | ||||||
| 06/21/2022 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $33.04 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 05/31/2022 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $34.58 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 05/24/2022 | Teva Pharmaceuticals USA, Inc. | — | Food and Beverage | In-kind items and services | $18.45 | General |
About Michael Barrow
Michael Barrow is a Gerontology healthcare provider based in Thomasville, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/08/2016. The National Provider Identifier (NPI) number assigned to this provider is 1497111207.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Michael Barrow has received a total of $1,453 in payments from pharmaceutical and medical device companies, with $125.02 received in 2024. These payments were reported across 59 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($1,453).
Practice Information
- Specialty Gerontology
- Location Thomasville, GA
- Active Since 01/08/2016
- Last Updated 01/08/2016
- Taxonomy Code 363LG0600X
- Entity Type Individual
- NPI Number 1497111207
Products in Payments
- INGREZZA (Drug) $226.41
- ARISTADA (Drug) $221.59
- VRAYLAR (Drug) $178.10
- ABILIFY MAINTENA (Drug) $173.81
- HETLIOZ (Drug) $124.38
- INVEGA SUSTENNA (Drug) $96.42
- REXULTI (Drug) $76.90
- BRIXADI (Drug) $61.00
- UZEDY (Drug) $50.17
- VIVITROL (Drug) $43.86
- PERSERIS (Drug) $42.90
- AUSTEDO (Drug) $35.72
- CAPLYTA (Drug) $32.01
- SUBLOCADE (Drug) $27.53
- Auvelity (Drug) $23.44
- ABILIFY ASIMTUFII (Drug) $19.93
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.